Overview

Vascular and Metabolic Effects of Vytorin

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The investigator hypothesize that vytorin may improve vascular and insulin resistance in hypercholesterolemic patients
Phase:
Phase 4
Details
Lead Sponsor:
Gachon University Gil Medical Center
Treatments:
Ezetimibe, Simvastatin Drug Combination